< Back to Schedule

Parallel Session: Hepatitis B: Therapeutics (New)

Sunday, November 15
2:00 pm
3:30 pm


No items found.

About the Session

Watch this live session to see some the top research in Hepatitis B. Content will only be aired on this date, at this time. Don't miss it!

  • Novel HLA-E Specific IMMTAV® Molecules for the Treatment of Hepatitis B
    Presenting Author Sarah Leonard
  • HBsAg Reduction by Nasal Administration of a Therapeutic Vaccine Containing HBsAG and HBCAG (NASVAC) in Patients with Chronic HBV Infection: The Results of 18 Months Follow Up
    Presenting Author Osamu Yoshida
  • Targeting Hbx by CRISPR/Cas9 System effectively Reduces the EMT and STEMNESS Characteristics of HCC Cells In Vitro
    Presenting Author Preety Rawal
  • Novel Anti-HBV Therapies Using CRISPR/Cas9 Targeting HBV Genome Strongly Suppress HBV
    Presenting Author Kazuhiro Murai
  • Safety and Pharmacodynamics of the Galnac-siRNA AB-729 in Subjects with Chronic Hepatitis B Infection
    Presenting Author Man-Fung Yuen
  • Combination of Antisense Oligonucleotides (ASOS) ALG -020572 and ALG-020576 Against Hepatitis B Virus (HBV) Improves Activity and can be Combined with Other Anti-HBV Agents
    Presenting Author Jin Hong